Metagenomi Inc (MGX)

$1.52 +0.04 (2.70%)
Market Cap 56.82M
Revenue (ttm) 52.30M
Net Income (ttm) -78.06M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -149.25%
Debt to Equity Ratio 0.00
Volume 331,100
Avg Vol 439,168
Day's Range N/A - N/A
Shares Out 37.38M
Stochastic %K 72%
Beta -0.27
Analysts Strong Sell
Price Target $15.60

Latest News on MGX

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Mar 17, 2025, 4:05 PM EDT - 4 weeks ago

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Mar 13, 2025, 6:19 AM EDT - 5 weeks ago

Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

Feb 11, 2025, 8:55 AM EST - 2 months ago

Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

Jan 16, 2025, 8:55 AM EST - 3 months ago

Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

Metagenomi Announces New Appointment to its Board of Directors

Jan 15, 2025, 8:55 AM EST - 3 months ago

Metagenomi Announces New Appointment to its Board of Directors

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Jan 8, 2025, 4:05 PM EST - 3 months ago

Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

Dec 11, 2024, 6:30 PM EST - 4 months ago

Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Dec 9, 2024, 9:16 PM EST - 4 months ago

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Nov 25, 2024, 11:30 AM EST - 5 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Nov 25, 2024, 9:56 AM EST - 5 months ago

FINAL DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Nov 24, 2024, 9:37 AM EST - 5 months ago

MGX Deadline: Rosen Law Firm Urges Metagenomi, Inc. (NASDAQ: MGX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Assist The Schall Law Firm

Nov 23, 2024, 5:15 PM EST - 5 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Affected Stockholders Are Urged To Assist The Schall Law Firm

MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit

Nov 23, 2024, 1:00 PM EST - 5 months ago

MGX Deadline: MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit

DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024

Nov 22, 2024, 11:59 AM EST - 5 months ago

DEADLINE NEXT WEEK: Berger Montague Advises Metagenomi (NASDAQ: MGX) Investors to Contact the Firm Before November 25, 2024

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Nov 21, 2024, 12:00 PM EST - 5 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Are Urged To Contact The Schall Law Firm

Shareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights – MGX

Nov 20, 2024, 12:41 PM EST - 5 months ago

Shareholders of Metagenomi, Inc. Should Contact The Gross Law Firm Before November 25, 2024 to Discuss Your Rights – MGX

The Schall Law Firm Invites Investor Participation In A Fraud Case Against Metagenomi Inc

Nov 20, 2024, 11:00 AM EST - 5 months ago

The Schall Law Firm Invites Investor Participation In A Fraud Case Against Metagenomi Inc

The Schall Law Firm Invites Investors To Join A Fraud Case Against Metagenomi Inc

Nov 18, 2024, 1:30 PM EST - 5 months ago

The Schall Law Firm Invites Investors To Join A Fraud Case Against Metagenomi Inc

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

Nov 17, 2024, 3:00 PM EST - 5 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Nov 14, 2024, 9:18 PM EST - 5 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Metagenomi, Inc. Is Being Sued For Violating Securities Regulations And Shareholders With Losses Are Urged To Help The Schall Law Firm

Nov 13, 2024, 1:15 PM EST - 5 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Regulations And Shareholders With Losses Are Urged To Help The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Nov 11, 2024, 4:00 PM EST - 5 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Assist The Schall Law Firm

Nov 11, 2024, 2:45 PM EST - 5 months ago

Metagenomi, Inc. Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Encouraged To Assist The Schall Law Firm

Metagenomi, Inc. May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Nov 9, 2024, 12:30 PM EST - 5 months ago

Metagenomi, Inc. May Have Violated Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

The Schall Law Firm Encourages Investor Participation In A Fraud Case Against Metagenomi Inc

Nov 4, 2024, 11:00 AM EST - 5 months ago

The Schall Law Firm Encourages Investor Participation In A Fraud Case Against Metagenomi Inc

Lawsuit Deadline Notice: Metagenomi, Inc. Investors who lost over $100,000 with NASDAQ: MGX shares should contact the Shareholders Foundation

Oct 29, 2024, 1:35 PM EDT - 6 months ago

Lawsuit Deadline Notice: Metagenomi, Inc. Investors who lost over $100,000 with NASDAQ: MGX shares should contact the Shareholders Foundation